Home » Topics » Regulatory » Patents

Patents
RSS

The University of Kansas identifies new endoplasmin inhibitors

March 20, 2019

BioTheryX patents IL-1beta, IL-6, IL-2 and TNF-alpha production inhibitors

March 20, 2019

New Tec family kinase inhibitors synthesized at GB005

March 20, 2019

Plex Pharmaceuticals presents dual FKBP12/FKBP52 inhibitors

March 20, 2019

Newave Pharmaceutical discloses new Bcl-2 inhibitors

March 20, 2019

ACADIA Pharmaceuticals presents 5-HT2A receptor ligands

March 19, 2019

Sprint Bioscience synthesizes PIK3C3 inhibitors

March 19, 2019

Asceneuron discloses OGA inhibitors

March 19, 2019

Novartis patent describes compounds for cancer

March 19, 2019

Idorsia patents antibacterial pyrroloimidazolones

March 19, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...